HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.

AuthorsA Hiraoka, H Shibata, T Masaoka
JournalTransplantation proceedings (Transplant Proc) Vol. 24 Issue 6 Pg. 3047-8 (Dec 1992) ISSN: 0041-1345 [Print] United States
PMID1466051 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Adjuvants, Immunologic
  • Leucine
  • ubenimex
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Administration, Oral
  • Adolescent
  • Adult
  • Bone Marrow Transplantation (immunology)
  • Child
  • Child, Preschool
  • Chronic Disease
  • Female
  • Graft vs Host Disease (immunology)
  • Graft vs Host Reaction (immunology)
  • Humans
  • Infant
  • Leucine (administration & dosage, analogs & derivatives)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (immunology, surgery)
  • Leukemia, Myeloid, Acute (immunology, surgery)
  • Male
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: